Humacyte (HUMA) Other Non-Current Assets (2020 - 2026)

Humacyte (HUMA) has reported Other Non-Current Assets for 7 consecutive years, with $672000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Assets fell 98.66% year-over-year to $672000.0 in Q2 2026; TTM through Jun 2026 was $672000.0, a 98.66% decrease from a year earlier, with the FY2025 full-year figure at $672000.0, down 98.66% from the prior year.
• Other Non-Current Assets was $672000.0 for Q2 2026 at Humacyte, roughly flat from $672000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $50.4 million in Q3 2024 and troughed at $632000.0 in Q4 2023.
• A 5-year average of $16.0 million and a median of $815000.0 in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets jumped 7844.46% in 2024 and sank 98.67% in 2025, its largest moves.
• Over 5 years, Other Non-Current Assets stood at $682000.0 in 2022, then decreased by 7.33% to $632000.0 in 2023, then jumped by 7844.46% to $50.2 million in 2024, then sank by 98.66% to $672000.0 in 2025, then changed by 0.0% to $672000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $672000.0 (Q2 2026), $672000.0 (Q1 2026), and $672000.0 (Q4 2025), per Business Quant data.